Parametric Portfolio Associates LLC reduced its position in Cigna Corp (NYSE:CI) by 8.8% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,168,694 shares of the health services provider’s stock after selling 113,349 shares during the quarter. Parametric Portfolio Associates LLC’s holdings in Cigna were worth $184,128,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in CI. Redhawk Wealth Advisors Inc. acquired a new stake in Cigna in the second quarter valued at about $28,000. TRUE Private Wealth Advisors acquired a new position in Cigna during the 2nd quarter worth approximately $40,000. Prime Capital Investment Advisors LLC increased its position in Cigna by 32.5% during the 2nd quarter. Prime Capital Investment Advisors LLC now owns 257 shares of the health services provider’s stock worth $40,000 after purchasing an additional 63 shares during the period. Trustcore Financial Services LLC purchased a new position in shares of Cigna during the 1st quarter worth approximately $49,000. Finally, Glassman Wealth Services raised its stake in shares of Cigna by 33.3% during the 2nd quarter. Glassman Wealth Services now owns 320 shares of the health services provider’s stock worth $50,000 after buying an additional 80 shares in the last quarter. Institutional investors own 87.46% of the company’s stock.

In other Cigna news, CEO David Cordani bought 32,509 shares of the company’s stock in a transaction on Monday, September 9th. The stock was purchased at an average cost of $155.17 per share, for a total transaction of $5,044,421.53. Company insiders own 0.80% of the company’s stock.

Several research analysts have issued reports on the company. Sanford C. Bernstein upgraded Cigna from a “market perform” rating to an “outperform” rating and set a $205.00 price objective for the company in a research report on Tuesday, August 6th. Zacks Investment Research lowered shares of Cigna from a “buy” rating to a “hold” rating and set a $164.00 target price on the stock. in a research report on Tuesday, June 11th. Raymond James upped their price target on shares of Cigna from $185.00 to $190.00 and gave the stock an “outperform” rating in a research note on Friday, August 2nd. ValuEngine downgraded shares of Cigna from a “hold” rating to a “sell” rating in a report on Tuesday, July 23rd. Finally, Stephens set a $225.00 price target on shares of Cigna and gave the company a “buy” rating in a report on Friday, August 23rd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $212.82.

Cigna stock traded down $3.40 during trading hours on Wednesday, hitting $161.59. The stock had a trading volume of 106,445 shares, compared to its average volume of 1,884,858. Cigna Corp has a 1-year low of $141.95 and a 1-year high of $226.60. The stock has a market capitalization of $61.70 billion, a price-to-earnings ratio of 11.36, a PEG ratio of 0.83 and a beta of 0.73. The stock’s fifty day moving average is $161.20 and its two-hundred day moving average is $161.85. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.70 and a quick ratio of 0.70.

Cigna (NYSE:CI) last released its quarterly earnings results on Thursday, August 1st. The health services provider reported $4.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.74 by $0.56. Cigna had a return on equity of 13.24% and a net margin of 3.60%. The business had revenue of $34.38 billion during the quarter, compared to the consensus estimate of $33.27 billion. During the same quarter in the previous year, the company posted $3.89 EPS. The business’s revenue was up 198.9% on a year-over-year basis. As a group, sell-side analysts anticipate that Cigna Corp will post 16.75 EPS for the current year.

About Cigna

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Featured Story: What are the risks of holding treasury bonds?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.